Clinical trial No longer in our active list Interventional

Postpartum family planning program in Rwanda

Official title: Implementation and Evaluation of a Large-scale Postpartum Family Planning Program in Rwanda

Run by Emory University · NCT05056545 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new program to help new mothers in Rwanda access long-lasting birth control to improve their health and the health of their babies.

Quick facts

Study typeInterventional
SexAll
Enrollment26215 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Kigali, Kigali Province)
Trial IDNCT05056545 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include postpartum women up to 14 weeks postpartum receiving antenatal care or postpartum services at participating health facilities.

Probably not a fit

Patients who are prisoners will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to address the high unmet need for postpartum family planning (PPFP) in Rwanda by implementing a multi-level intervention that has shown success in pilot testing. The intervention focuses on increasing the uptake of long-acting reversible contraceptives (LARCs) among postpartum women through collaboration with healthcare providers and community health workers. By utilizing an implementation science framework, the study will evaluate the effectiveness and sustainability of the PPFP intervention in 10 high-volume health facilities in Kigali. The goal is to adapt the intervention for large-scale implementation to improve maternal and newborn health outcomes.

Why it matters

Potential benefit: If successful, this program could significantly reduce unintended pregnancies and improve maternal and newborn health in Rwanda.

How similar studies have gone: Previous pilot studies have shown significant success with similar approaches in increasing the uptake of postpartum family planning methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligible PPFP promoters will be government facility providers working in ANC,L\&D, IV and/or postpartum services at one of the study facilities.
* Eligible PPFP providers will be government facility providers working in L\&D, and/or family planning services at one of the study facilities.
* Eligible Happy Client promotors will be postpartum women who received promotions and selected a PPFP method.
* Eligible nurse/midwife and CHW promotors will be women working as nurses or CHWs at one of the intervention facilities.
* All women eligible for PPFP services in this study will be at any stage of pregnancy or up to 14 weeks postpartum, and receiving antenatal care (ANC), L\&D, IV, or postpartum services at one of the intervention or pilot facilities

Exclusion Criteria:

* Prisoners

Where it's running

  • Project San Francisco, Kigali
    Kigali, Kigali Province, Rwanda
    Recruiting

Study contacts

  • Principal investigator: Kristin Wall, PhD — Emory University
  • Study coordinator: Kristin Wall, PhD
  • Email: kmwall@emory.edu
  • Phone: 404-727-9088

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.